This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hundley, J. E.
Right arrow Articles by Windle, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hundley, J. E.
Right arrow Articles by Windle, J. J.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 02 1997, 723-731, Vol 17, No. 2
Copyright © 1997, American Society for Microbiology

Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53

JE Hundley, SK Koester, DA Troyer, SG Hilsenbeck, MA Subler and JJ Windle
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, 78284, USA.

We have used an in vivo tumor model to evaluate the consequences of p53 tumor suppressor protein deficiency in a tissue-specific context. By breeding MMTV-ras transgenic mice, which are highly susceptible to the development of mammary and salivary tumors, with p53(-/-) mice, we generated three classes of animals which contained the MMTV-ras transgene but differed in their p53 functional status (ras/p53(+/+), ras/p53(+/-), or ras/p53(-/-)). ras/p53(-/-) mice developed tumors more rapidly than animals of the other two genotypes; however, the distribution of tumors was unexpectedly altered. Whereas the most frequently observed tumors in ras/p53(+/+) and ras/p53(+/-) mice were of mammary origin, ras/p53(-/-) mice developed primarily salivary tumors. In addition, the mammary and salivary tumors from ras/p53(-/-) mice consistently exhibited a number of unfavorable characteristics, including higher histologic grades, increased growth rates, and extensive genomic instability and heterogeneity, relative to tumors from ras/p53(+/+) mice. Interestingly, the increased growth rates of ras/p53(-/-) tumors appear to be due to impaired cell cycle regulation rather than decreased apoptosis, suggesting that p53-mediated tumor suppression can occur independent of its role in apoptosis.


This article has been cited by other articles:

  • Ozturk, N., Lee, J. H., Gaddameedhi, S., Sancar, A. (2009). Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc. Natl. Acad. Sci. USA 106: 2841-2846 [Abstract] [Full Text]  
  • Barboza, J. A., Liu, G., Ju, Z., El-Naggar, A. K., Lozano, G. (2006). p21 delays tumor onset by preservation of chromosomal stability. Proc. Natl. Acad. Sci. USA 103: 19842-19847 [Abstract] [Full Text]  
  • Houle, C. D., Ton, T.-V. T., Clayton, N., Huff, J., Hong, H.-H. L., Sills, R. C. (2006). Frequent p53 and H-ras Mutations in Benzene- and Ethylene Oxide-Induced Mammary Gland Carcinomas from B6C3F1 Mice. Toxicol Pathol 34: 752-762 [Abstract] [Full Text]  
  • Tront, J. S., Hoffman, B., Liebermann, D. A. (2006). Gadd45a Suppresses Ras-Driven Mammary Tumorigenesis by Activation of c-Jun NH2-Terminal Kinase and p38 Stress Signaling Resulting in Apoptosis and Senescence.. Cancer Res. 66: 8448-8454 [Abstract] [Full Text]  
  • Yeh, E. S., Lew, B. O., Means, A. R. (2006). The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability. J. Biol. Chem. 281: 241-251 [Abstract] [Full Text]  
  • Ho, J. S. L., Ma, W., Mao, D. Y. L., Benchimol, S. (2005). p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest. Mol. Cell. Biol. 25: 7423-7431 [Abstract] [Full Text]  
  • Martin, K. R., Jokinen, M. P., Honeycutt, H. P., Quinn, A., Kari, F. W., Barrett, J. C., French, J. E. (2004). Tumor Spectrum in the p53 Heterozygous Zeta Globin-Promoted Tg.AC (v-Ha-ras) Bitransgenic Mouse Model. Toxicol Pathol 32: 418-425 [Abstract]  
  • Yu, R., Lu, W., Chen, J., McCabe, C. J., Melmed, S. (2003). Overexpressed Pituitary Tumor-Transforming Gene Causes Aneuploidy in Live Human Cells. Endocrinology 144: 4991-4998 [Abstract] [Full Text]  
  • Andarawewa, K. L., Boulay, A., Masson, R., Mathelin, C., Stoll, I., Tomasetto, C., Chenard, M.-P., Gintz, M., Bellocq, J.-P., Rio, M.-C. (2003). Dual Stromelysin-3 Function during Natural Mouse Mammary Tumor Virus-ras Tumor Progression. Cancer Res. 63: 5844-5849 [Abstract] [Full Text]  
  • Petit, T., Bearss, D. J., Troyer, D. A., Munoz, R. M., Windle, J. J. (2003). p53-independent Response to Cisplatin and Oxaliplatin in MMTV-ras Mouse Salivary Tumors. Molecular Cancer Therapeutics 2: 165-171 [Abstract] [Full Text]  
  • Fong, L. Y. Y., Ishii, H., Nguyen, V. T., Vecchione, A., Farber, J. L., Croce, C. M., Huebner, K. (2003). p53 Deficiency Accelerates Induction and Progression of Esophageal and Forestomach Tumors in Zinc-deficient Mice. Cancer Res. 63: 186-195 [Abstract] [Full Text]  
  • Bearss, D. J., Lee, R. J., Troyer, D. A., Pestell, R. G., Windle, J. J. (2002). Differential Effects of p21WAF1/CIP1 Deficiency on MMTV-ras and MMTV-myc Mammary Tumor Properties. Cancer Res. 62: 2077-2084 [Abstract] [Full Text]  
  • Lu, X., Magrane, G., Yin, C., Louis, D. N., Gray, J., Van Dyke, T. (2001). Selective Inactivation of p53 Facilitates Mouse Epithelial Tumor Progression without Chromosomal Instability. Mol. Cell. Biol. 21: 6017-6030 [Abstract] [Full Text]  
  • Shin, D. M., Charuruks, N., Lippman, S. M., Lee, J. J., Ro, J. Y., Hong, W. K., Hittelman, W. N. (2001). p53 Protein Accumulation and Genomic Instability in Head and Neck Multistep Tumorigenesis. Cancer Epidemiol. Biomarkers Prev. 10: 603-609 [Abstract] [Full Text]  
  • Kemp, C. J., Sun, S., Gurley, K. E. (2001). p53 Induction and Apoptosis in Response to Radio- and Chemotherapy in Vivo Is Tumor-Type-dependent. Cancer Res. 61: 327-332 [Abstract] [Full Text]  
  • Rowinsky, E. K., Windle, J. J., Von Hoff, D. D. (1999). Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development. JCO 17: 3631-3652 [Abstract] [Full Text]  
  • Lee, K. C., Crowe, A. J., Barton, M. C. (1999). p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding. Mol. Cell. Biol. 19: 1279-1288 [Abstract] [Full Text]  
  • Chen, C.-Y., Liou, J., Forman, L. W., Faller, D. V. (1998). Differential Regulation of Discrete Apoptotic Pathways by Ras. J. Biol. Chem. 273: 16700-16709 [Abstract] [Full Text]  
  • Paulson, T. G., Almasan, A., Brody, L. L., Wahl, G. M. (1998). Gene Amplification in a p53-Deficient Cell Line Requires Cell Cycle Progression under Conditions That Generate DNA Breakage. Mol. Cell. Biol. 18: 3089-3100 [Abstract] [Full Text]  
  • Barrington, R. E., Subler, M. A., Rands, E., Omer, C. A., Miller, P. J., Hundley, J. E., Koester, S. K., Troyer, D. A., Bearss, D. J., Conner, M. W., Gibbs, J. B., Hamilton, K., Koblan, K. S., Mosser, S. D., O'Neill, T. J., Schaber, M. D., Senderak, E. T., Windle, J. J., Oliff, A., Kohl, N. E. (1998). A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis. Mol. Cell. Biol. 18: 85-92 [Abstract] [Full Text]  
  • Yu, R., Heaney, A. P., Lu, W., Chen, J., Melmed, S. (2000). Pituitary Tumor Transforming Gene Causes Aneuploidy and p53-dependent and p53-independent Apoptosis. J. Biol. Chem. 275: 36502-36505 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»